
Scientists Engineer Gut Bacteria to Infiltrate Tumors and Manufacture Cancer Drugs From the Inside
A team at Shandong University modified the probiotic bacterium E. coli Nissle 1917 to seek out breast cancer tumors in mice, colonize them, and produce the FDA-approved drug Romidepsin directly at the tumor site — opening a potential new path for targeted chemotherapy with fewer systemic side effects.



